Table 1

Demographic, psychosocial and self-reported clinical characteristics for the total sample, and split by physical activity level (less than or at least 600 MET-min/week)†

<600 MET-min
n=98
≥600 MET-min
n=283
Total sample
n=381
Demographic characteristics
Age (years)62.2±9.862.4±9.862.4±9.9
Gender*
  Man
  Woman
45 (45.9%)
53 (54.1%)
163 (57.6%)
120 (42.4%)
208 (54.6%)
173 (45.4%)
Marital status
  Single
  Married
  De facto (unmarried cohabitation)
  Divorced
  Widowed
  Other
9 (9.2%)
67 (68.4%)
3 (3.1%)
8 (8.2%)
7 (7.1%)
4 (4.1%)
26 (9.2%)
208 (73.5%)
12 (4.2%)
16 (5.7%)
18 (6.4%)
3 (1.1%)
35 (9.2%)
275 (72.2%)
15 (3.9%)
24 (6.3%)
25 (6.6%)
7 (1.8%)
Country of birth
  Australia76 (77.6%)218 (77%)294 (77.2%)
BMI (kg/m2)**34.7±7.431.0±7.732.0±7.8
  Underweight
  Normal range
  Overweight
  Obese
0 (0%)
7 (7.1%)
27 (27.6%)
64 (65.3%)
0 (0%)
53 (18.7%)
101 (35.7%)
129 (45.6%)
0 (0%)
60 (15.7%)
128 (33.6%)
193 (50.7%)
Education
  Year 10 or below
  Year 12
  Vocational
  Tertiary
16 (16.3%)
12 (12.2%)
33 (33.7%)
37 (37.8%)
36 (12.7%)
27 (9.5%)
102 (36.0%)
118 (41.7%)
52 (13.6%)
39 (10.2%)
135 (35.4%)
155 (40.7%)
Employment
  Full time
  Part time
  Retired
  Not working
29 (29.6%)
11 (11.2%)
45 (45.9%)
13 (13.3%)
64 (22.6%)
49 (17.3%)
148 (52.3%)
22 (7.8%)
93 (24.4%)
60 (15.7%)
193 (50.7%)
35 (9.2%)
Household income (annual)
  Up to $20 000
  $20 000–$40 000
  $40 000–$60 000
  $60 000–$100 000
  Above $100 000
18 (18.4%)
33 (33.7%)
9 (9.2%)
20 (20.4%)
18 (18.4%)
46 (16.3%)
69 (24.4%)
52 (18.4%)
56 (19.8%)
60 (21.2%)
64 (16.8%)
102 (26.8%)
61 (16.0%)
76 (19.9%)
78 (20.5%)
Psychosocial characteristics
Depressive symptoms (WHO-5)
  Total score**
  Impaired well-being (<13)**
12.3±5.7
53 (54.1%)
15.8±5.4
74 (26.1%)
14.9±5.7
127 (33.3%)
Self-efficacy (BARSE) total score**4.3 (3.2, 5.4)6.6 (4.8, 8.2)5.8 (4.1, 7.6)
Clinical characteristics
Diabetes duration (years)8.7±9.68.3±7.48.4±8.0
HbA1c, % (mmol/mol) (n=252)7.1±1.2 (54±5)7.1±4.8 (54±29)7.1±4.3 (54±23)
Diabetes management
  Insulin treatment
  Non-insulin treatment
27 (27.6%)
71 (72.4%)
63 (22.3%)
220 (77.7%)
90 (23.6%)
291 (76.4%)
Diabetes comorbidities*
  Per participant
  Total ≥1 comorbidity
1 (0, 2)
56 (57.1%)
0 (0, 1)
129 (45.6%)
0 (0, 1)
184 (48.3%)
  • *p<0.05; **p<0.01.

  • †All data are mean±SD, median (IQR) or n (%).

  • BARSE, Barriers Self-Efficacy; BMI, body mass index.